Alexander Muavcevic
Papers
1
Total Citations
9
H-Index
1
About
Alexander Muavcevic has made pioneering contributions to the field of stereotactic body radiotherapy, with a focused expertise in treating liver metastases using robotic radiosurgical devices. His most-cited work, a 2018 study on long-term survival in patients treated with the CyberKnife system for liver metastases, has garnered 9 citations and addresses a critical gap in oncological literature—providing much-needed long-term efficacy data for non-surgical, ablative treatments. By demonstrating that robotic radiosurgery can achieve survival outcomes comparable to surgical resection in select patients, Muavcevic’s research has helped validate this modality as a viable, less invasive alternative for metastatic liver disease. His work directly informs clinical decision-making for patients who are not candidates for surgery, expanding treatment options in a rapidly evolving field. Beyond this landmark paper, Muavcevic’s broader research agenda centers on optimizing dose delivery, minimizing toxicity, and improving patient selection for radiosurgery. His contributions are particularly valuable for students and researchers interested in the intersection of radiation oncology, medical physics, and surgical oncology, offering a compelling evidence base for the role of advanced radiation technologies in managing oligometastatic disease.
Research Focus
Key Achievements
Top Papers
- 1